Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
Public ClinicalTrials.gov record NCT02625181. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02625181
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Vanderbilt University
- Other
- Enrollment
- 27,034 participants
Conditions and interventions
Conditions
Interventions
- Automated recommendation at the start of the case Procedure
- Automated notification at the start of surgery Procedure
- Preoperative recommendations: by email Procedure
- Automated notification at the end of surgery Procedure
- Anesthesia Information Management System (AIMS) Device
- Perioperative Data Warehouse (PDW) Device
- General anesthesia Procedure
- Elective surgery Procedure
- Propofol Drug
- Sevoflurane Drug
- Isoflurane Drug
- Desflurane Drug
- Scopolamine Drug
- Droperidol Drug
- Haloperidol Drug
- Dexamethasone Drug
- Promethazine Drug
- Meclizine Drug
- Aprepitant Drug
- Metoclopramide Drug
- Fentanyl Drug
- Sufentanil Drug
- Alfentanil Drug
- Remifentanil Drug
- Morphine Drug
- Meperidine Drug
- Hydromorphone Drug
- Methadone Drug
- Oxycodone Drug
- Oxymorphone Drug
- Hydrocodone Drug
- Ketamine Drug
- Ondansetron Drug
- Granisetron Drug
- Dolasetron mesylate Drug
- Palonosetron Drug
- Tropisetron Drug
- Ramosetron Drug
Procedure · Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016
- Primary completion
- Nov 1, 2017
- Completion
- Nov 29, 2017
- Last update posted
- Mar 6, 2019
2016 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02625181, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02625181 live on ClinicalTrials.gov.